Mayo Clinic Cardiovascular CME cover art

All Episodes

Mayo Clinic Cardiovascular CME — 113 episodes

#
Title
1

Inflammatory Aortic Aneurysms

2

Pulsed Field Ablation for Atrial Fibrillation with Left Atrial Appendage Occlusion

3

What the Cardiologist Needs to Know About Marfan Syndrome

4

Contraception Decision Making for Pre-Menopausal Women with Cardiovascular Disease

5

Differential Diagnosis and Workup of Thoracic Aortic Aneurysm

6

The Central Role of Cardiac MRI in the Management of Heart Failure and Cardiomyopathy Patients

7

AI in Imaging: How Will it Change What We Do

8

Menopause Management In Women with Cardiovascular Disease

9

Handheld Ultrasound and Detection of Valve and Other Structural Heart Disease

10

What Do I Need to Know About Pulsed Field Ablation?

11

Cardiovascular Care of the Masters Athlete

12

Pregnancy, Labor and Delivery, and Postpartum Care in Women with Cardiovascular Disease

13

AI ECG for Valvular Disease and Diastolic Function

14

Preconception Counseling for High-Risk Women

15

Common Scenarios in ACHD

16

Menorrhagia Management in Women with Cardiovascular Disease

17

ACHD for the Primary Care Provider

18

Pacing and Defibrillation Without Leads

19

The Hospitalized ACHD Patient

20

Does Lifestyle Affect Pregnancy and Congenital Birth Defects?

21

Gene Therapy and Genetic Cardiomyopathies

22

Leadless Pacemakers and Extravascular ICDs

23

Translating the DGA Into Real-World Cardiometabolic Care

24

Applications of the New DGA

25

Dietary Guidelines for Americans: What Changed, What Didn’t, and Why it Matters

26

Conduction System Pacing

27

AI Detection of Cardiac Amyloidosis

28

Clopidogrel Monotherapy in Chronic Coronary Artery Disease

29

Global Practices in Cardiac Imaging for Cardiac Sarcoidosis

30

Anticoagulation Monotherapy in Patients with Chronic Coronary Artery Disease and Atrial Fibrillation

31

Updated Guidelines for Perioperative Cardiovascular Management for Noncardiac Surgery

32

Obesity, Hypertension, and Risk Factors in Terms of Prevention and Decreasing the Risk of HfpEF

33

Aortic Regurgitation: Beyond the Valve

34

Presentation, Evaluation, and Management of Premature Ventricular Contractions

35

Tricuspid Regurgitation: New Insights and Implications for Clinical Practice

36

Cardiovascular Diet Myths

37

Evolving Treatment Landscape in Transthyretin Cardiac Amyloidosis

38

Radiation Therapy and its Effect on the Heart and Cardiac Devices

39

When to Consider Intervention for Peripheral Arterial Disease

40

Heart Healthy Diet: How to Evaluate Your Patients

41

2024 Peripheral Arterial Guidelines: What’s New

42

Patients Struggling With SVT/AVNRT and Catheter Ablation

43

Effects of Social Isolation and Loneliness on the Heart

44

Ischemia with No Obstructive Arteries (INOCA) in 2024

45

Statin Myopathy

46

Recent Updates in AF Guidelines

47

Patient Selection and the Role of Echo Imaging for Tricuspid Structural Heart Procedures

48

What is ECG Age Vs. Chronological age, and How to Use it in Your CV Prevention Practice

49

Robotic Cardiac Surgery

50

Anticoagulation with AF and Cancer

51

Ceramide Risk Score: How to Incorporate it Into Your CV Prevention Practice

52

CT Scan for Coronary Artery Calcification Window

53

Management of Postoperative Pericarditis

54

How a Years Worth of Experience of PFA for AF has Revolutionized My Practice

55

Lipoprotein (a) Elevation: What Does it do to CV Risk and What do You Need to Know About Treatment

56

How to Tell Patients about Adding in Intervals to Their Physical Activity Program

57

Role of Thrombophilia Testing in Venous Thromboembolism

58

Electrophysiology Considerations in Oncology Patients

59

Chronic Total Occlusion in 2025

60

Supplements for Cardiovascular Prevention

61

Role of Genetics in the Heart Failure Clinic

62

Assessing Recurrence Following Pulsed Field Ablation for Atrial Fibrillation

63

Hybrid Procedures Collaboration with Interventional Cardiology

64

Interval Training – What Does the Science Tell Us About the Benefits Versus Continuous Activity

65

Secrets to Achieving CAD Regression

66

Association Between COVID-19 Vaccination and Atrial Arrhythmias in Individuals with Cardiac Implantable Electronic Devices

67

Updates in Left Atrial Appendage Closure

68

Lifestyle Modification in the Setting of New Prevention Therapies

69

Latest Developments in the Treatment of Pulmonary Arterial Hypertension

70

Exploring New Frontiers in Rhythm Monitoring Technology

71

Updates from the 2024 ESC and AHA Scientific Statements on Cardiac Sarcoidosis

72

New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia

73

Myocarditis: What’s New in 2025

74

Post-Cardiac Ablation Atrial Arrhythmia Monitoring

75

Lipid Drugs: Part 2

76

Lipid Drugs: Part 1

77

Heart Lung Transplantation

78

Mayo Clinic's Experience with Cardioneural Ablation

79

Aortic Valve Prosthesis Selection

80

Current Nutritional Controversies- What is the Science Behind the Current Trends in Mainstream Media?

81

Can CT Angiography Be Used to Track CAD Regression?

82

Myth-Busting: Common Misconceptions About Dairy and Heart Health, Personalized Nutrition and Dairy, & Practical Tips for Heart-Healthy Dairy Consumption

83

The Role of Saturated Fats in Dairy & Dairy Alternatives and Their Impact

84

Antiplatelets After Stenting

85

Introduction to Dairy and Cardiovascular Health & The Science Behind Dairy and Heart Health

86

Modeling Disease Pathways Through Ventricular Depolarization

87

Role of Denervation for Hypertension Management

88

Chronic Thrombo-Embolic Pulmonary Hypertension

89

Arrhythmias in Pregnancy

90

AI ECG Updates

91

Optimal Medical Therapy in Peripheral Artery Disease

92

Dyspnea After Pulmonary Embolism

93

MINOCA: Myocardial Infarction with Non-Obstructive Coronary Arteries

94

An AI-ECG Algorithm for Left Ventricular Diastolic Dysfunction

95

Novel Mitral Therapies

96

Myocarditis - Presentation and Recent Advances

97

Valve Disease in Pregnancy

98

Cardioneural ablation for atrial fibrillation: Indications and rationale

99

Interventional Management of Acute Pulmonary Embolism

100

Cardiac Amyloidosis: No Longer Rare and Untreatable!

101

IV Agents to Improve Echo Images, Value, and Safe Administration

102

Cardioneural Ablation - A Promising Treatment Strategy for Refractory Vasovagal Syncope

103

Pre-Pregnancy Risk Assessment for CV Patients

104

Cardio-oncology: What is the Big Picture, What Drugs to Use, and What Tests to Follow

105

Clinical Quantification of Myocardial Blood Flow Using PET

106

3D Visualization of the Heart in Immersive Technology Like Mixed Reality

107

Marfan Surgery

108

Hypertensive Disorders of Pregnancy and CV Risk

109

Genomics in Inflammatory Cardiomyopathies

110

Understanding ECG Waveforms: Normal vs. Abnormal

111

Recurrent Pericarditis: when is surgical pericardiectomy indicated

112

Surgical Pericardiectomy for Constrictive Pericarditis

113

Cardiogenic Shock Recognition